CAD 0.14
(-6.67%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 12.61 Million USD | 235.19% |
2022 | -9.33 Million USD | -400.13% |
2021 | 3.1 Million USD | 110.56% |
2020 | -29.44 Million USD | 33.79% |
2019 | -44.48 Million USD | 39.06% |
2018 | -72.98 Million USD | -1283.12% |
2017 | -5.27 Million USD | -847.4% |
2016 | -557 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 27.75 Million USD | 28.33% |
2024 Q1 | 21.62 Million USD | 71.45% |
2023 Q4 | 12.61 Million USD | 60.35% |
2023 FY | 12.61 Million USD | 235.19% |
2023 Q1 | -2.72 Million USD | 70.82% |
2023 Q2 | -2.64 Million USD | 2.86% |
2023 Q3 | 7.86 Million USD | 397.43% |
2022 Q2 | 6.89 Million USD | -7.65% |
2022 Q4 | -9.33 Million USD | -316.5% |
2022 FY | -9.33 Million USD | -400.13% |
2022 Q1 | 7.46 Million USD | 139.98% |
2022 Q3 | 4.31 Million USD | -37.45% |
2021 Q1 | -12.64 Million USD | 57.05% |
2021 FY | 3.1 Million USD | 110.56% |
2021 Q4 | 3.1 Million USD | 36.0% |
2021 Q3 | 2.28 Million USD | 143.48% |
2021 Q2 | -5.25 Million USD | 58.42% |
2020 Q2 | -74.38 Million USD | -154.79% |
2020 Q1 | -29.19 Million USD | 34.36% |
2020 FY | -29.44 Million USD | 33.79% |
2020 Q4 | -29.44 Million USD | 29.11% |
2020 Q3 | -41.53 Million USD | 44.16% |
2019 Q3 | -14.72 Million USD | 65.57% |
2019 Q2 | -42.75 Million USD | 34.07% |
2019 Q1 | -64.85 Million USD | 11.14% |
2019 FY | -44.48 Million USD | 39.06% |
2019 Q4 | -44.48 Million USD | -202.09% |
2018 Q3 | -78.86 Million USD | -671.99% |
2018 Q1 | -8.97 Million USD | -70.06% |
2018 Q2 | -10.21 Million USD | -13.84% |
2018 Q4 | -72.98 Million USD | 7.45% |
2018 FY | -72.98 Million USD | -1283.12% |
2017 Q4 | -5.27 Million USD | 0.0% |
2017 FY | -5.27 Million USD | -847.4% |
2016 FY | -557 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aurora Cannabis Inc. | -8.64 Million CAD | 245.872% |
Avicanna Inc. | 1.32 Million CAD | -851.215% |
Avant Brands Inc. | 17.93 Million CAD | 29.643% |
Cardiol Therapeutics Inc. | -34.77 Million CAD | 136.278% |
Crescita Therapeutics Inc. | -8.13 Million CAD | 255.147% |
Knight Therapeutics Inc. | 10.33 Million CAD | -22.12% |
MediPharm Labs Corp. | -15.68 Million CAD | 180.422% |
OrganiGram Holdings Inc. | -33.7 Million CAD | 137.423% |
Canopy Growth Corporation | 512.87 Million CAD | 97.54% |
Willow Biosciences Inc. | -989 Thousand CAD | 1375.531% |
Auxly Cannabis Group Inc. | 142.88 Million CAD | 91.171% |